Items where authors include "Daniel, A"

Article

Daniel, A, Hallam, A, Desaules, J-Y et al. (4 more authors) (2023) Bridging quantum criticality via many-body scarring. Physical Review B: Condensed Matter and Materials Physics, 107 (23). 235108. ISSN 1098-0121

Desaules, J-Y orcid.org/0000-0002-3749-6375, Bull, K, Daniel, A et al. (1 more author) (2022) Hypergrid subgraphs and the origin of scarred quantum walks in many-body Hilbert space. Physical Review B: Condensed Matter and Materials Physics, 105 (24). 245137. ISSN 1098-0121

Afzal, N, Basit, A, Daniel, A et al. (10 more authors) (2022) Quantifying Food Waste in the Hospitality Sector and Exploring Its Underlying Reasons—A Case Study of Lahore, Pakistan. Sustainability, 14 (11). 6914. ISSN 2071-1050

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Daniel, A, Bagnato, G, Vital, E orcid.org/0000-0003-1637-4755 et al. (1 more author) (2017) Chylous ascites in a patient with an overlap syndrome: a surprising response to rituximab. BMJ Case Reports. bcr-2017-222339. ISSN 1757-790X